October 22, 2014: Activist hedge fund Third Point called on biotech Amgen to split into two companies in a letter yesterday to company shareholders, as the fund continued to press Amgen, in which it has a significant stake, to increase its value.
October 22, 2014: After a string of slow quarterly revenue, UK-based GlaxoSmithKline announced today that it will undergo major restructuring over the next five years in the hopes of cutting costs by £1 billion.
October 22, 2014: Roche announced today that it will spend approximately 1.9 billion pounds, or approximately $3 billion, to upgrade its Basel site as it invests in a new research and development center and upgrades existing buildings.
October 21, 2014: Here's BioSpace's guide to who's working on therapeutics or vaccines for Ebola and how those pipelines are progressing. Companies that are not included in the list but are also developing Ebola treatments are encouraged to contact BioSpace.